Spinal Degenerative Disorder clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Ailliance Post-Market Clinical Study
open to eligible people ages 18 years and up
The purpose of this clinical study is to collect performance and safety data for post-market Medtronic devices indicated for cranial and/or spinal indication(s). Subjects are enrolled and followed postoperatively for up to 24 months. The Ailliance clinical study is intended to collect data congruous with routine clinical care practices.
at UCSF
Our lead scientists for Spinal Degenerative Disorder research studies include Aaron Clark, MD.
Last updated: